R&D

Pipeline

Combination Therapies

Pipeline
파이프라인 후보물질 전임상 임상1상 임상2상 임상3상 비고
MB-110(PDI inhibitors) Protein-DNA interaction inhibotor
MB-610(Drug repositioning) Known Factor M inhibitor
MB-620(Drug repositioning) FDA 승인 drug library에서 Factor M inhibitor 예비 선도 물질 발굴

Companion Diagnostics

Pipeline
Biomarker
Selection
Feasibility Prototype
Assay
Analytical
Validation
Clinical & Analytical
Validation
Regulatory
Approval
Post Approval
MB-CDx
검색 닫기